12 reports

asthma; under this segment, the company provides medicines to treat HIV, lupus, benign prostatic hyperplasia, type ## diabetes, bacterial infections, and others; the company also provides extensive portfolio of more than ## pediatric, adolescent, adult, and travel vaccines Consumer healthcar

  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY

MDD HAS ALSO BEEN LINKED TO CARDIOVASCULAR DISEASE, DIABETES, ASTHMA, OBESITY, AND SEVERAL ADVERSE HEALTH BEHAVIORS, SUCH AS SMOKING, PHYSICAL INACTIVITY, AND HIGH ALCOHOL INTAKE (STRINE ET AL., 2008).

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.

GSK has a diversified portfolio of products and provides assistance in treating major diseases such as asthma, cancer, infections, mental health, diabetes, and digestive conditions, and in viral diseases.

  • Depression
  • United States
  • Actavis plc
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • XPRO-1595 - DRUG PROFILE
  • DEPRESSION - PIPELINE BY SUMITOMO DAINIPPON PHARMA CO LTD, H2 2017

This patent, which expires in 2032 protects to the use of masitinib in the treatment of severe persistent corticosteroid-dependent asthma and severe persistent corticosteroidresistant asthma.

  • Depression
  • Mental Health
  • Pharmaceutical
  • Therapy
  • Anavex Life Sciences Corp.
  • PIPELINE BY JOHNSON & JOHNSON, H2 2017

asthma and allergy disorders, anxiety, epilepsy, and cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage (aSAH).

  • Depression
  • Sleep Aid
  • Therapy
  • United States
  • Product Initiative

Asthma, Diabetic Neuropathic Pain, Diabetic Neuropathy Ongoing, recruiting Phase I Interventional HX-## Hydra Biosciences Inc ## Mar 2016 ## ## Transient Receptor Potential Cation Channel Subfamily A Member ## (Ankyrin Like With Transmembrane Domains Protein ## or Transformation Sensitive Pro

  • Chronic Pain
  • Clinical Trial
  • Depression
  • Pharmaceutical
  • Eli Lilly & Co.
  • SCHIZOPHRENIA - PIPELINE BY SUNOVION PHARMACEUTICALS INC
  • SCHIZOPHRENIA - PIPELINE BY SUVEN LIFE SCIENCES LTD

The existing product portfolio and the pipeline candidates are targeted for treating patients of epilepsy, anxiety, depression, asthma, pain, allergic rhinitis and chronic obstructive pulmonary diseases.

  • Depression
  • Mental Health
  • United States
  • Product Initiative
  • Pfizer Inc.

It is in Phase II stage of development for the treatment of polymyalgia rheumatica, major depressive disorder and severe asthma.

  • Depression
  • Pharmaceutical
  • United States
  • Product Initiative
  • Allergan plc
  • XPRO-1595 - DRUG PROFILE

This patent, which expires in 2032 protects to the use of masitinib in the treatment of severe persistent corticosteroid-dependent asthma and severe persistent corticosteroidresistant asthma.

  • Depression
  • Mental Health
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Drug Profiles

It is in Phase II stage of development for major depressive disorder and severe asthma.

  • Depression
  • Opioid
  • United States
  • Product Initiative
  • Allergan plc

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Depression
  • United States
  • World
  • Company
  • Product Initiative
  • % Acquired Deal Financials

Lundbeck A/ S AWD-##-## (GW ##) was under development for the treatment of asthma, chronic obstructive pulmonary disease (COPD), atopic dermatitis and allergic rhinitis.

  • Depression
  • Psychotic Disorder
  • United States
  • Company
  • H. Lundbeck A/S